Pulse Biosciences, Inc. is a cutting-edge medical technology company that focuses on developing and commercializing innovative healthcare solutions using its proprietary Nano-Pulse Stimulation™ (NPS) technology.
Based in Hayward, California, Pulse Biosciences is pioneering a new category of energy-based therapies designed to treat a variety of skin conditions, tumors, and other diseases by delivering ultra-short electrical pulses to targeted cells.
This non-thermal, precise method disrupts cellular function and induces apoptosis without damaging surrounding tissue, offering a unique approach to medical treatment. The company’s lead product, the CellFX® System, is designed to treat dermatologic conditions and has already gained traction among healthcare professionals.
Pulse Biosciences’ growth is driven by its ongoing research and development efforts, expansion of its product portfolio, and the increasing adoption of its technology in the medical field. With a strong focus on innovation and patient outcomes, Pulse Biosciences is positioned to make significant strides in the healthcare industry, offering promising new treatment options for patients.
